COVID 19 & Diabetes

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Rayman G, Lumb A, Kennon B, Cottrell D, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.
Diabetic Medicine 2021;38(1):e14378

COVID 19 And Diabetes Presentation

Dhatariya K.

A Covid-19 response action – diabetes management in care homes.

Sinclair AJ, Dhatariya K, Burr O, Nagi D, Kar P, Jones D, Newland-Jones P, Higgins K, Patel M, Abdelhafiz A, Hopkins D, Howarth D, O’Neill S, Gooday C.
Diabetic Medicine. 2020;37(7):1090-1093

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voight D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland Jones P, Stewart R, Burr O, Thomas S.
Diabetic Medicine. 2020;37(7):1214-1216

“COVID 19 and Diabetes” – Africa Webinar May 2020

Dhatariya K.

Diabetes Type 2 & COVID 19 Video

Dhatariya K.

Diabetes Type 1 & COVID 19 Video

Dhatariya K.